Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update

Rhea-AI Summary

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) has announced that it will report its second quarter 2024 financial results after market close on Tuesday, August 6, 2024. The company's senior management will host a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and provide a business update. Participants can join the call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The call and accompanying slides will also be webcast live from the Investor Relations section of Rigel's website at www.rigel.com, where it will be archived for 90 days after the call.

SOUTH SAN FRANCISCO, Calif., July 30, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2024 financial results after market close on Tuesday, August 6, 2024. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2024-financial-results-and-business-update-302209261.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel Pharmaceuticals (RIGL) report its Q2 2024 financial results?

Rigel Pharmaceuticals (RIGL) will report its second quarter 2024 financial results after market close on Tuesday, August 6, 2024.

How can investors access Rigel's (RIGL) Q2 2024 earnings call?

Investors can access Rigel's Q2 2024 earnings call by dialing 877-407-3088 (domestic) or 201-389-0927 (international), or by joining the webcast from the Investor Relations section of Rigel's website at www.rigel.com.

What time is Rigel Pharmaceuticals' (RIGL) Q2 2024 earnings call scheduled?

Rigel Pharmaceuticals' (RIGL) Q2 2024 earnings call is scheduled for 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) on Tuesday, August 6, 2024.

How long will the webcast of Rigel's (RIGL) Q2 2024 earnings call be available?

The webcast of Rigel's (RIGL) Q2 2024 earnings call will be archived and available for replay for 90 days after the call via the company's website.